Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting

Stock Track

05-20

Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.

The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.

During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1126892586"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126892586\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1126892586?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-20 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126892586","market":"nz","top_or_hot":-1,"title":"Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting","media":"Stock Track","content":"<p>Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.</p>\n\n<p>The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.</p>\n\n<p>During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Legend Biotech Soars 5% as Company Announces Investor Event at ASCO Annual Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-20 03:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.</p>\n\n<p>The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.</p>\n\n<p>During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LEGN","symbol_name":"传奇生物","start_time":0,"source_url":"","article_id":"1126892586","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126892586","pubTimestamp":1747683626,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Legend Biotech Corporation  saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology  Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LEGN":"传奇生物"},"translate_title":"传奇生物科技(Legend Biotech)在ASCO年会上宣布投资者活动，股价飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LEGN":1},"content_text":"Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.\nThe biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.\nDuring the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}